ERYTHROMYCIN, 8,9-DIDEHYDRO-9-DEOXO-6-DEOXY-6,9-EPOXY-, (9S)-
UNII Q225NZM7BP
Substance Identification & Data
This profile provides standardized clinical and technical data for Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy-, (9s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q225NZM7BP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 857839-61-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H65NO12 JFVYXJKGJMUGRG-MGSLXKPGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy-, (9s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.